Drug Approvals
🇺🇸 FDA Page 12FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 133–144 of 665 articles
FDA Issues Final Guidance for Pulmonary Tuberculosis Drug Development
FDA · pulmonary tuberculosis · 5 min
Dr. Sarah MitchellBiosimilars Drive Significant Reductions in Specialty Drug Spending
9 min
Dr. Sarah MitchellALX Oncology to Present at 2026 Jefferies Global Healthcare Conference, Highlighting Oncology Pipeline
oncology · 6 min
Dr. Sarah MitchellLegend Biotech's In Vivo CAR-T Data Sparks Stock Surge: A Catalyst Tracking Analysis
8 min
Dr. Sarah MitchellAdvancing Bladder Cancer Care Through Education and Awareness
FDA · bladder cancer · 6 min
Dr. Sarah MitchellASCO ‘26: Bispecifics, ADCs, and the RAS Revolution Reshape Oncology
prostate cancer · 7 min
Dr. Sarah MitchellThis Week’s Biopharma News: New Approvals, Appeals, and AI
FDA · 10 min
Dr. Sarah MitchellTissue TMB Superior to Blood TMB in Predicting Immunotherapy Response, Cleveland Clinic Study Finds
Tumor Mutation Burden · 7 min
Dr. Sarah MitchellCelcuity's Gedatolisib: Navigating the Path to Broad FDA Approval in Breast Cancer
FDA · breast cancer · 8 min
Dr. Sarah MitchellFDA Delays Decision on AstraZeneca's Camizestrant Following Negative Adcomm Vote
FDA · breast cancer · 9 min
Dr. Sarah MitchellFDA Declines Cingulate's ADHD Drug CTx-1301 Over Manufacturing Concerns
FDA · ADHD · 9 min
Dr. Sarah MitchellASCO 2026 Preview: Key Data and Trends in Cancer Research
pancreatic cancer · 7 min
Dr. Sarah MitchellExplore intelligence